Met Life Investment Management, LLC Agenus Inc Transaction History

Met Life Investment Management, LLC

  • $17.1 Billion
  • Q3 2024

Shares

58 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024
BUY
$0.53 - $0.93 $80,694 - $141,595
152,253 New
152,253 $88,000
Q3 2023

May 09, 2024
BUY
$1.12 - $1.88 $47,352 - $79,484
42,279 Added 30.41%
181,313 $204,000
Q2 2023

Apr 29, 2024
BUY
$1.31 - $2.04 $237,520 - $369,878
181,313 New
181,313 $290,000
Q2 2023

Aug 10, 2023
BUY
$1.31 - $2.04 $55,385 - $86,249
42,279 Added 30.41%
181,313 $290,000
Q1 2023

May 09, 2024
BUY
$1.45 - $2.95 $201,599 - $410,150
139,034 New
139,034 $211 Million
Q1 2023

May 15, 2023
SELL
$1.45 - $2.95 $30,347 - $61,740
-20,929 Reduced 13.08%
139,034 $211,000
Q4 2022

May 10, 2024
BUY
$2.02 - $3.25 $33,933 - $54,596
16,799 Added 11.73%
159,963 $383,000
Q4 2022

Jun 14, 2023
BUY
$2.02 - $3.25 $42,276 - $68,019
20,929 Added 15.05%
159,963 $383,000
Q4 2022

Mar 22, 2023
BUY
$2.02 - $3.25 $33,933 - $54,596
16,799 Added 11.73%
159,963 $383,000
Q4 2022

Feb 15, 2023
BUY
$2.02 - $3.25 $33,933 - $54,596
16,799 Added 11.73%
159,963 $383,000
Q3 2022

May 10, 2024
BUY
$1.96 - $3.14 $47,349 - $75,856
24,158 Added 20.3%
143,164 $293,000
Q3 2022

Jun 14, 2023
BUY
$1.96 - $3.14 $8,094 - $12,968
4,130 Added 2.97%
143,164 $293,000
Q3 2022

Mar 22, 2023
BUY
$1.96 - $3.14 $47,349 - $75,856
24,158 Added 20.3%
143,164 $293,000
Q3 2022

Nov 14, 2022
BUY
$1.96 - $3.14 $47,349 - $75,856
24,158 Added 20.3%
143,164 $293,000
Q2 2022

May 10, 2024
BUY
$1.3 - $2.64 $27,652 - $56,155
21,271 Added 21.76%
119,006 $230,000
Q2 2022

Jun 20, 2023
SELL
$1.3 - $2.64 $26,036 - $52,873
-20,028 Reduced 14.41%
119,006 $230,000
Q2 2022

Mar 22, 2023
BUY
$1.3 - $2.64 $27,652 - $56,155
21,271 Added 21.76%
119,006 $230,000
Q2 2022

Aug 11, 2022
BUY
$1.3 - $2.64 $27,652 - $56,155
21,271 Added 21.76%
119,006 $231,000
Q1 2022

May 10, 2024
BUY
$2.35 - $3.47 $229,677 - $339,140
97,735 New
97,735 $240,000
Q1 2022

Jun 20, 2023
SELL
$2.35 - $3.47 $97,052 - $143,307
-41,299 Reduced 29.7%
97,735 $240,000
Q1 2022

Mar 22, 2023
BUY
$2.35 - $3.47 $43,428 - $64,125
18,480 Added 23.32%
97,735 $240,000
Q1 2022

May 12, 2022
BUY
$2.35 - $3.47 $43,428 - $64,125
18,480 Added 23.32%
97,735 $240,000
Q4 2021

May 17, 2024
BUY
$2.92 - $5.74 $59,822 - $117,595
20,487 Added 34.86%
79,255 $255,000
Q4 2021

Jun 21, 2023
SELL
$2.92 - $5.74 $174,554 - $343,131
-59,779 Reduced 43.0%
79,255 $255,000
Q4 2021

Mar 22, 2023
BUY
$2.92 - $5.74 $59,822 - $117,595
20,487 Added 34.86%
79,255 $255,000
Q4 2021

Feb 15, 2022
BUY
$2.92 - $5.74 $59,822 - $117,595
20,487 Added 34.86%
79,255 $255,000
Q3 2021

May 17, 2024
SELL
$4.98 - $6.63 $73,415 - $97,739
-14,742 Reduced 20.05%
58,768 $308,000
Q3 2021

Jun 21, 2023
SELL
$4.98 - $6.63 $399,724 - $532,163
-80,266 Reduced 57.73%
58,768 $308,000
Q3 2021

Mar 22, 2023
SELL
$4.98 - $6.63 $73,415 - $97,739
-14,742 Reduced 20.05%
58,768 $308,000
Q3 2021

Nov 15, 2021
SELL
$4.98 - $6.63 $73,415 - $97,739
-14,742 Reduced 20.05%
58,768 $309,000
Q2 2021

May 17, 2024
BUY
$2.56 - $5.49 $118,589 - $254,318
46,324 Added 170.4%
73,510 $403,000
Q2 2021

Jun 21, 2023
SELL
$2.56 - $5.49 $167,741 - $359,726
-65,524 Reduced 47.13%
73,510 $403,000
Q2 2021

Mar 22, 2023
BUY
$2.56 - $5.49 $118,589 - $254,318
46,324 Added 170.4%
73,510 $403,000
Q2 2021

Aug 16, 2021
BUY
$2.56 - $5.49 $118,589 - $254,318
46,324 Added 170.4%
73,510 $404,000
Q1 2021

May 17, 2024
SELL
$2.69 - $5.25 $336,430 - $656,601
-125,067 Reduced 82.14%
27,186 $73,000
Q1 2021

Jun 26, 2023
SELL
$2.69 - $5.25 $300,871 - $587,202
-111,848 Reduced 80.45%
27,186 $73.9 Million
Q1 2021

Mar 22, 2023
SELL
$2.69 - $5.25 $112,226 - $219,030
-41,720 Reduced 60.55%
27,186 $73,000
Q1 2021

May 14, 2021
SELL
$2.69 - $5.25 $112,226 - $219,030
-41,720 Reduced 60.55%
27,186 $74,000
Q4 2020

May 24, 2024
BUY
$3.17 - $4.49 $13,485 - $19,100
4,254 Added 6.58%
68,906 $219,000
Q4 2020

Jun 22, 2023
SELL
$3.17 - $4.49 $222,305 - $314,874
-70,128 Reduced 50.44%
68,906 $219,000
Q4 2020

Mar 22, 2023
BUY
$3.17 - $4.49 $13,485 - $19,100
4,254 Added 6.58%
68,906 $219,000
Q4 2020

Feb 16, 2021
BUY
$3.17 - $4.49 $13,485 - $19,100
4,254 Added 6.58%
68,906 $219,000
Q3 2020

Jun 26, 2023
SELL
$2.98 - $5.2 $221,658 - $386,786
-74,382 Reduced 53.5%
64,652 $258,000
Q2 2020

May 24, 2024
SELL
$2.29 - $4.24 $200,606 - $371,428
-87,601 Reduced 57.54%
64,652 $254 Million
Q2 2020

Jun 26, 2023
SELL
$2.29 - $4.24 $170,334 - $315,379
-74,382 Reduced 53.5%
64,652 $254,000
Q2 2020

Mar 22, 2023
BUY
$2.29 - $4.24 $42,621 - $78,914
18,612 Added 40.43%
64,652 $254,000
Q2 2020

Aug 14, 2020
BUY
$2.29 - $4.24 $42,621 - $78,914
18,612 Added 40.43%
64,652 $254,000
Q1 2020

Jul 12, 2023
SELL
$1.92 - $4.39 $178,548 - $408,243
-92,994 Reduced 66.89%
46,040 $112,000
Q4 2019

Jul 12, 2023
SELL
$2.41 - $4.4 $224,115 - $409,173
-92,994 Reduced 66.89%
46,040 $187,000
Q3 2019

Jul 12, 2023
SELL
$2.17 - $3.14 $201,796 - $292,001
-92,994 Reduced 66.89%
46,040 $118,000
Q2 2019

Jul 12, 2023
SELL
$2.53 - $3.04 $235,274 - $282,701
-92,994 Reduced 66.89%
46,040 $138,000
Q1 2019

Jul 13, 2023
SELL
$2.51 - $3.73 $233,414 - $346,867
-92,994 Reduced 66.89%
46,040 $136,000
Q4 2018

Jul 13, 2023
SELL
$1.59 - $2.66 $147,860 - $247,364
-92,994 Reduced 66.89%
46,040 $109,000
Q4 2018

Mar 22, 2023
SELL
$1.59 - $2.66 $181,137 - $303,035
-113,923 Reduced 71.22%
46,040 $109,000
Q4 2018

Feb 14, 2019
BUY
$1.59 - $2.66 $73,203 - $122,466
46,040 New
46,040 $110,000
Q2 2018

Aug 15, 2018
SELL
$2.26 - $4.65 $43,005 - $88,484
-19,029 Closed
0 $0
Q1 2018

May 15, 2018
SELL
$3.51 - $6.04 $66,897 - $115,116
-19,059 Reduced 50.04%
19,029 $90,000
Q4 2017

Feb 15, 2018
BUY
$3.26 - $4.78 $124,166 - $182,060
38,088
38,088 $124,000

Others Institutions Holding AGEN

# of Institutions
8
Shares Held
2.07M
Call Options Held
0
Put Options Held
0
View Full List

About AGENUS INC

AGEN Quotes by TradingView
  • Ticker AGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 283,163,008
  • Market Cap $4.73B
  • Description
  • Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...
More about AGEN
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email